Mesoblast (MESO) Income from Continuing Operations: 2014-2023
Historic Income from Continuing Operations for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to -$21.6 million.
- Mesoblast's Income from Continuing Operations fell 2.34% to -$21.6 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$81.9 million, marking a year-over-year increase of 10.35%. This contributed to the annual value of -$102.1 million for FY2025, which is 16.13% down from last year.
- Per Mesoblast's latest filing, its Income from Continuing Operations stood at -$21.6 million for Q2 2023, which was down 15.42% from -$18.7 million recorded in Q1 2023.
- Over the past 5 years, Mesoblast's Income from Continuing Operations peaked at -$9.3 million during Q3 2019, and registered a low of -$29.4 million during Q1 2019.
- Over the past 3 years, Mesoblast's median Income from Continuing Operations value was -$21.5 million (recorded in 2022), while the average stood at -$22.0 million.
- As far as peak fluctuations go, Mesoblast's Income from Continuing Operations surged by 55.32% in 2019, and later slumped by 178.18% in 2020.
- Quarterly analysis of 5 years shows Mesoblast's Income from Continuing Operations stood at -$29.1 million in 2019, then rose by 12.03% to -$25.6 million in 2020, then dropped by 1.90% to -$26.1 million in 2021, then increased by 5.66% to -$24.6 million in 2022, then decreased by 2.34% to -$21.6 million in 2023.
- Its Income from Continuing Operations stands at -$21.6 million for Q2 2023, versus -$18.7 million for Q1 2023 and -$24.6 million for Q4 2022.